Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Qurgen
AddedFeb 15, 2024
UpdatedJun 18, 2026
Qurgen

Qurgen

Series A

Qurgen, an Iowa-based biotech firm, specializes in stem cell technology and efficient protein development since 2016.

HQ
Troy, MI, US
Founded
2016
Overview
Compare
Fundraising
Employees

Qurgen, an Iowa-based biotech firm founded in 2016, specializes in stem cell technology and efficient protein development. The company focuses on breakthrough protein-targeted transport and efficient in vitro and in vivo protein-induced stem cells, offering advanced cell and tissue reprogramming technologies.

Qurgen has achieved significant milestones with its patented technologies, contributing to advancements in biotechnology and regenerative medicine. Its innovative approaches have positioned it as a leader in the field, impacting both research and clinical applications.

Qurgen - Similar Companies

QurAlis logo

QurAlis

Endogena Therapeutics logo

Endogena Therapeutics

Q Biotech logo

Q Biotech

q-biotech.com

iReprogram logo

iReprogram

ireprogram.com

AIxCrypto logo

AIxCrypto

InGeneron logo

InGeneron

ingeneron.com

Qatch Technologies logo

Qatch Technologies

qatchtech.com

Regenemed logo

Regenemed

regenemed.com

Spheringenics logo

Spheringenics

42Bio logo

42Bio

42bio.com

Histogen logo

Histogen

histogen.com

Primegen Biotech logo

Primegen Biotech

CasTag Biosciences logo

CasTag Biosciences

Surrozen logo

Surrozen

surrozen.com

Stemgenics logo

Stemgenics

stemgenics.com

Qurgen - Quick Facts

Who are Qurgen's competitors?

Companies similar to Qurgen include QurAlis, Endogena Therapeutics, Q Biotech and iReprogram.

When was Qurgen founded?

Qurgen was founded in 2016.

Where is Qurgen's headquarters located?

Qurgen's headquarters is located in Troy, MI, US.

When was Qurgen's last funding round?

Qurgen's most recent funding round was for $4.5M (USD) in February 2018.

How much has Qurgen raised to-date?

As of Feb 13, 2018, Qurgen has raised a total of $9.7M (USD).

How many employees does Qurgen have?

Qurgen has 6 employees as of Feb 5, 2024.

Qurgen - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotechnology
  • Stem Cell
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software